21, 2025, the semaglutide shortage was over and gave compounding pharmacies a deadline to stop distributing identical copies of FDA-approved Wegovy and Ozempic
Clinical trials and studies have indicated that Tirzepatide, through its dual-action mechanism, can benefit those looking to lose weight, regardless of their diabetic status
In 2025, increased clinical success of oral GLP-1 drugs for weight loss and broader approvals by regulatory bodies have driven demand among individuals seeking non-invasive, effective obesity treatment options
But when we eat, the hormone insulin gets to work, says Cleveland Clinic
PlexusDx providers stay current with emerging research
Reduced food noise: The mental quieting of food preoccupation allows patients to make more deliberate food choices rather than responding to constant hunger signals